Quote:
Could be an convenient/interesting strategy. Utilises vaccines where known to be most effective and allows them to skip hardest to reach age groups and get straight into 55-65 year olds in mass vaccination sites.
While I’m sceptical of the real world performance of the AZ vaccine on the ground - and I think we can see Government are particularly concerned that 62% reduced by the 1 dose strategy doesn’t give much headroom against the new UK/SA hybrid variant - my cynicism goes in all directions.
|
Not to worry, we’re going to get the AstraZeneca vaccine into the arms of a very large number of people here, and the data coming from that will soon leave them looking silly.
It is a strange decision really, and hard to understand unless they think the quantities of the various vaccines they expect to receive mean they won’t end up leaving their most vulnerable citizens waiting longer, with the attendant risk, before they get any kind of vaccine at all.
I’m curious though, whether your scepticism is based on a deeper understanding of the science, or just general cynicism?